ATE252888T1 - Lipid haltige zusammenstellungen und deren verwendungen - Google Patents

Lipid haltige zusammenstellungen und deren verwendungen

Info

Publication number
ATE252888T1
ATE252888T1 AT98940374T AT98940374T ATE252888T1 AT E252888 T1 ATE252888 T1 AT E252888T1 AT 98940374 T AT98940374 T AT 98940374T AT 98940374 T AT98940374 T AT 98940374T AT E252888 T1 ATE252888 T1 AT E252888T1
Authority
AT
Austria
Prior art keywords
compositions containing
containing lipids
lipids
biochemistry
lipid
Prior art date
Application number
AT98940374T
Other languages
English (en)
Inventor
Stephen Ronald Tonge
Brian John Tighe
Original Assignee
Univ Aston
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Aston filed Critical Univ Aston
Application granted granted Critical
Publication of ATE252888T1 publication Critical patent/ATE252888T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0082—Lung surfactant, artificial mucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
AT98940374T 1997-08-22 1998-08-24 Lipid haltige zusammenstellungen und deren verwendungen ATE252888T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9717905.5A GB9717905D0 (en) 1997-08-22 1997-08-22 Lipid-containing compositions and uses thereof
PCT/GB1998/002546 WO1999009955A2 (en) 1997-08-22 1998-08-24 Lipid-containing compositions and uses thereof

Publications (1)

Publication Number Publication Date
ATE252888T1 true ATE252888T1 (de) 2003-11-15

Family

ID=10817944

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98940374T ATE252888T1 (de) 1997-08-22 1998-08-24 Lipid haltige zusammenstellungen und deren verwendungen

Country Status (11)

Country Link
US (1) US6436905B1 (de)
EP (1) EP1007002B1 (de)
JP (1) JP2001513544A (de)
AT (1) ATE252888T1 (de)
AU (1) AU752508B2 (de)
CA (1) CA2301711C (de)
DE (1) DE69819338T2 (de)
ES (1) ES2210802T3 (de)
GB (1) GB9717905D0 (de)
NZ (1) NZ502839A (de)
WO (1) WO1999009955A2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6180142B1 (en) * 1998-08-21 2001-01-30 The Regents Of The University Of California Reduction of surfactant inactivation in pulmonary surfactant therapy
CN1592704A (zh) 2001-11-17 2005-03-09 艾文蒂斯药品有限公司 吸附剂及其使用
EP1498420B1 (de) 2002-03-29 2017-02-01 Nof Corporation Phospholipidderivat
US7531604B2 (en) 2002-09-30 2009-05-12 Nof Corporation Phospholipid derivative
JP4403303B2 (ja) 2003-01-06 2010-01-27 日油株式会社 リン脂質誘導体及びその製造方法
US7871818B2 (en) * 2003-01-31 2011-01-18 Roche Madison Inc. Membrane active polymers
WO2004083219A1 (ja) 2003-03-20 2004-09-30 Nof Corporation リン脂質誘導体
GB2426703B (en) * 2005-05-31 2007-09-19 Malvern Cosmeceutics Ltd Compositions
WO2007047498A2 (en) * 2005-10-14 2007-04-26 The Regents Of The University Of California Formation and encapsulation of molecular bilayer and monolayer membranes
US9233846B2 (en) * 2005-10-14 2016-01-12 The Regents Of The University Of California Formation and encapsulation of molecular bilayer and monolayer membranes
GB0601251D0 (en) * 2006-01-21 2006-03-01 Babraham Bioscience Technologi Protein solubilisation composition
GB2442202A (en) * 2006-09-30 2008-04-02 Morvus Technology Ltd Vermin poison
GB0623838D0 (en) 2006-11-29 2007-01-10 Malvern Cosmeceutics Ltd Novel compositions
EP1932517A3 (de) * 2006-12-11 2008-07-16 Universiteit Utrecht Holding B.V. Liposomen beinhaltend Polyphenolderivaten und deren Verfahren zur Nachbeladung
EP2091585B1 (de) * 2006-12-15 2010-12-15 Bausch & Lomb Incorporated Oberflächenbehandlung biomedizinischer vorrichtungen
WO2009143425A1 (en) * 2008-05-22 2009-11-26 The Regents Of The University Of California Membrane precursors and membranes formed therefrom
US9333445B2 (en) 2008-07-21 2016-05-10 Becton, Dickinson And Company Density phase separation device
WO2011004158A1 (en) * 2009-07-08 2011-01-13 The University Of Birmingham Solubilisation of membrane proteins
EP2521650A4 (de) 2010-01-05 2013-05-15 Univ California Tröpfchendoppelschichtbildung durch behandlungsverfahren für geleitete flüssigkeiten
GB201107737D0 (en) 2011-05-09 2011-06-22 Univ Birmingham Extraction from cells
US9150598B2 (en) 2011-10-05 2015-10-06 The Regents Of The University Of California Masking apertures enabling automation and solution exchange in sessile bilayers
GB201312343D0 (en) * 2013-07-10 2013-08-21 Univ Aston Lipid-Containing Nanoparticle
US10829571B2 (en) 2017-08-31 2020-11-10 Texas Tech University System Polymer-encased nanodiscs with improved buffer compatibility
GB201909680D0 (en) 2019-07-05 2019-08-21 Malvern Cosmeceutics Ltd Hypercoiling polymer derivatives
CN115364111B (zh) * 2021-05-17 2024-04-02 中国医学科学院基础医学研究所 甘油磷脂类化合物在治疗肿瘤中的用途
GB2608837A (en) 2021-07-13 2023-01-18 Univ Stellenbosch Zwitterionic polymers for forming nanodiscs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6461424A (en) * 1987-09-01 1989-03-08 Yamanouchi Pharma Co Ltd Smancs preparation dispersible in administration
JP2699038B2 (ja) * 1992-02-21 1998-01-19 株式会社ノエビア 温度感受性リポソーム
US5374420A (en) * 1993-01-22 1994-12-20 Revlon Consumer Products Corporation Hair setting compositions
US5436010A (en) * 1993-07-30 1995-07-25 Sdg Technology, Inc. Hair penetrant and carrier
WO1995011700A1 (en) * 1993-10-29 1995-05-04 Pharmos Corp. Submicron emulsions as vaccine adjuvants

Also Published As

Publication number Publication date
DE69819338D1 (de) 2003-12-04
EP1007002A1 (de) 2000-06-14
CA2301711C (en) 2007-04-24
AU752508B2 (en) 2002-09-19
AU8871498A (en) 1999-03-16
US6436905B1 (en) 2002-08-20
WO1999009955A2 (en) 1999-03-04
DE69819338T2 (de) 2004-07-15
ES2210802T3 (es) 2004-07-01
NZ502839A (en) 2003-01-31
WO1999009955A3 (en) 1999-07-08
CA2301711A1 (en) 1999-03-04
GB9717905D0 (en) 1997-10-29
EP1007002B1 (de) 2003-10-29
JP2001513544A (ja) 2001-09-04

Similar Documents

Publication Publication Date Title
ATE252888T1 (de) Lipid haltige zusammenstellungen und deren verwendungen
DK0783297T3 (da) Polyethylenglycol-modificerede ceramid-lipider og liposomer
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
AR004357A1 (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol, y procedimiento de preparacion para dichos compuestos.
CY1112687T1 (el) Μεθοδος για χρηση δικετοπιπεραζινων και συνθεσεις που περιλαμβανουν αυτες
DE69703294D1 (de) Zusammensetzungen die konjugate von cis-docosahexaenoic-säure und taxotere enthalten
NO984524D0 (no) Amfipatiske molekyler som kolesterol- og andre lipoidopptaksinhibitorer
DK0879589T3 (da) Nanoemulsion på basis af ikke-ioniske amfifile lipider og aminerede siliconer samt anvendelser
DE69925276D1 (de) Stoffe und zusammensetzungen für die verabreichung aktiver substanzen
ATE383169T1 (de) Komponente und zusammensetzungen zur verabreichung von wirkstoffen
EE200000388A (et) Ravimkoostis, mis sisaldab mitselle, mis sisaldavad lipofiilset glükokortikosteroidi ja ainult üht pindaktiivset ainet
DE69828038D1 (de) Lipidkomplexe von sehr unlöslichen platinkomplexen
FR2719468B1 (fr) Compositions cosmétiques à base de certains bioflavonoïdes et utilisations notamment dans le domaine capillaire.
ES2190082T3 (es) Concentrados estables de vitamina c.
BR9712498A (pt) Ingredientes de detergente de aminaquaternizados, alcoxilados
MA26486A1 (fr) Aryl- et heteroaryl-thiazolocetohydrazides inhibiteurs de proteases, et compositions pharmaceutiques les contenant .
ES2115400T3 (es) Dispositivo para el alojamiento de un soporte publicitario plano.
SE9802937D0 (sv) Novel compounds
BR0003766A (pt) Misturas de tensoativos compreendendo ácido graxo n-alquilpolihidroxiamidas e ácido graxo amidoalcoxilatos
DE69813287D1 (de) Lipidzusammensetzungen und deren verwendung
BR9802803A (pt) ação e composições farmacêuticas contendo os mesmos.
ATE28188T1 (de) Antikonvulsive mittel.
DE69841260D1 (de) Bakterielle pheromone und deren verwendungen
DK1011329T3 (da) 7-Methylthiooxomethyl- og 7-methylthiodioxomethyl-paclitaxeler
ES1041639Y (es) Conjunto para aplicacion de motivos graficos en el cabello.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1007002

Country of ref document: EP